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Abstract 
The present study examined riboflavin (RF) uptake by purified rat liver basolateral membrane vesicle (BLMV). Uptake of RF was 
found to be Na--and pH-independent i  nature. Studies on RF uptake by BLMV as a function of incubation medium osmolarity have 
indicated that the uptake is the result of transport (66.5%) into the intravesicular space as well as binding (33.5%) to membrane surfaces. 
The process of RF uptake by BLMV was saturable as a function of substrate concentration with an apparent K m of 3.55 4- 0.70 /zM and 
Vma x of 39.89 ___ 3.24 pmol/mg protein/5 s, respectively, cis-Addition of unlabeled RF and its structural analogs lumaflavin and 
lumichrome inhibited the uptake of [3H]RF while trans-addition of unlabeled RF stimulated the efflux of [3H]RF from preloaded vesicles. 
No effect on RF uptake was found by the membrane transport inhibitors probenecid, 4,4-diisothiocyanotostilbene-2,2-disulfonic acid 
(DIDS) and 4-acetamido-4-isothiocyanatostilbene-2,2'-disulfonic acid (SITS). Induction of a transient positive intravesicular space led to 
a slight stimulation of RF uptake, while induction of a negative intravesicular space led to a slight inhibition in RF uptake. These results 
demonstrate he existence of a membrane-associated carrier system for RF uptake by liver BLMV. This system appears to be Na ÷- and 
pH-independent and is influenced to a certain degree by changes in transmembrane el ctrical potential. 
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1. Introduction 
Riboflavin (RF) is a water-soluble vitamin, that is es- 
sential for normal cellular functions, growth and develop- 
ment [1-3]. In its coenzyme forms riboflavin 5'-phosphate 
(FMN) and flavin adenine dinucleotide (FAD), RF serves 
in key metabolic reactions including carbohydrate, amino 
acid and lipid metabolism, as well as in the conversion of 
pyridoxine into its coenzyme forms. Furthermore, a role 
for RF in the protection of tissues against oxidative injury 
has been recently advanced [4]. 
The liver plays an important role in normal RF home- 
ostasis and is a major site of RF metabolism and utiliza- 
tion. Hepatocytes obtain RF from the circulation via trans- 
port across the basolateral membrane (BLM). Limited 
studies are available describing the mechanism and regula- 
tion of RF uptake across the hepatocyte BLM. Aw et al. 
have utilized isolated rat hepatocytes in suspension and 
suggested the involvement of metabolic trapping (i.e., 
phosphorylation) in the uptake process [5]. Although a 
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useful technique, isolated hepatocytes in suspension cannot 
differentiate between uptake across the BLM domain of 
the polarized hepatocyte and that which takes place across 
its canalicular membrane domain. Also, use of this prepa- 
ration cannot eliminate the influence of substrate intra- 
cellular metabolism, i.e., metabolic trapping, of a substrate 
after uptake into the cell. In the case of RF, the liver 
contains significant flavokinase activity (which converts 
RF to FMN) and FAD synthetase activity (which converts 
FMN to FAD) [6,7]. Both of the above described compli- 
cations could, however, be significantly eliminated with 
the use of purified liver BLM vesicles (BLMV). In this 
study we therefore utilized this technique to study RF 
transport into liver cells, with special emphasis on examin- 
ing the existence of a specialized BLM-associated uptake 
system. 
2. Materials and methods 
[G-3H]Riboflavin (spec. act. 40 Ci /mmol ;  radiochemi- 
cal purity = 98%) was obtained from American Radiola- 
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beled Chemicals, St. Louis, MO. Unlabeled riboflavin, 
lumiflavin and lumichrome were purchased from Sigma, 
St. Louis. All other chemicals and reagents were obtained 
from commercial sources and were of analytical quality. 
Cellulose nitrate filters (pore size of 0.45 /xm) were pur- 
chased from Millipore, Bedford, MA. 
BLMV were isolated from the liver of Sprague-Dawley 
rats (Sasco, Omaha, NE) using a modification of Blitzer 
and Donovon's [8] self-generating Percoll gradient method 
described by us in detail previously [9]. Isolated liver 
vesicles were suspended in an uptake (intravesicular) buffer 
of 280 mM mannitol and 20 mM Hepes/Tris, pH 7.4 to an 
average protein concentration of 2.50 _+ 0.19 mg/ml. Up- 
take experiments were performed on freshly isolated 
BLMV utilizing a rapid-filtration technique [10] as de- 
scribed by us before [11], and were initiated by mixing 20 
/xl of BLMV suspension with 80 /zl of incubation buffer 
(in mM: NaCI or KC1 100, mannitol 80, Hepes/Tris 20, 
pH 7.4) containing labeled and unlabeled RF. Incubation 
was terminated at the desired time by the addition of l ml 
of ice-cold stop solution (in mM: NaC1 100, mannitol 100, 
KH2PO 4 10, pH 7.4) and the suspension was filtered then 
washed with 5 ml of ice-cold buffer. The filter was then 
dissolved in scintillation fluid and counted for radioactiv- 
ity. In the transstimulation study, liver BLMV were first 
preloaded with [3H]RF (5/zM) for 20 rain at room temper- 
ature, pelleted, washed with ice-cold buffer then suspended 
in ice-cold transport buffer. Vesicles were then incubated 
at 37°C for 30 s with 80 /~1 of incubation buffer in the 
presence and absence of 100/zM unlabeled RF. At the end 
of incubation, the reaction was stopped, the vesicles were 
filtered and their radioactive content was determined. 
The purity and suitability of rat liver BLMV for uptake 
studies have been demonstrated previously in our labora- 
tory by morphological (electron microscopy), enzymatic 
and functional criteria [9]. Vesicle orientation was also 
established by freeze-fracture electron microscopy and by 
[3H]ouabain binding assay [9]. Protein concentrations of
membrane vesicles were measured by the method of Lowry 
et al. [12] using BSA as the protein standard. Each data 
point presented in this communication is the means 4- S.E. 
of multiple separate uptake measurements from at least 
two different vesicle preparations from different rats and is 
expressed as pmol/mg protein/unit time. Data was ana- 
lyzed using regression analysis and the Student's t-test. As 
seen before with this membrane preparation [13,14], some 
quantitative variations in the absolute amount of RF uptake 
was noticed in some BLMV preparations. For this reason, 
appropriate controls were run with each experiment to 
permit comparison. Kinetic parameters of the observed 
saturable component of RF uptake (i.e., the Vma × and the 
apparent K m) were calculated using a computerized model 
of the Michaelis-Menten equation as described by Wilkin- 
son [15], following subtraction of the diffusion (and non- 
specific) component from total uptake. Contribution of 
diffusion to total uptake was determined by examining RF 
uptake in the presence of a high concentration of lumi- 
flavin (330 /zM) which causes a similar degree of inhibi- 
tion of the uptake as RF, see Results). The purity of the 
stock [3H]RF and the metabolic form of the radioactivity 
taken up by liver BLMV following incubation with [3H]RF 
were determined using silica-gel precoated TLC plates and 
a solvent system of ethanol and water (9:1, v /v)  [16]. 
3. Results 
3.1. General characteristics of RF uptake by liver BLMV 
Fig. 1 depicts the uptake of 0.11 /xM [3H]RF as a 
function of time in liver BLMV incubated in Na + and K + 
containing buffers (outside = 100 mM, inside = 0 mM). 
Following an initial rapid phase, uptake of RF increased 
linearly for up to 20 s of incubation but leveled off 
thereafter reaching equilibrium after approx. 60 s of incu- 
bation. The initial rapid phase of uptake represented by the 
intersection of the linear uptake line with the y-axis most 
probably represents binding of RF to BLM (see below for 
more evidence). No difference was found in RF uptake by 
BLMV incubated in the presence of a Na ÷ or a K ÷ 
gradient. Similar results were found for the uptake of high 
concentration f RF (20 /zM) with time (data not shown). 
In another study, the effect of varying the incubation 
buffer pH on the uptake of RF (0.11 /~M) by liver BLMV 
preloaded with transport buffer (pH 7.4) was examined. In 
these studies the buffering system of the incubation medium 
was either Hepes/Tris or Hepes/Mes. No effect of incu- 
bation buffer pH was found on RF uptake (uptake of 
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Fig. 1. Uptake of RF by rat liver BLMV as a function of time in the 
presence of a Na ÷ or a K + gradient. BLMV were preloaded with a 
buffer of 280 mM mannitol and 20 mM Hepes/Tris pH 7.4. Incubation 
was done in an incubation buffer of 100 mM NaCI (closed circles) or KCI 
(open circles), 80 mM Mannitol and 20 mM Hepes/Tris pH 7.4. [3H]RF 
(0.11 /zM) was added to the incubation medium at the onset of incuba- 
tion. Each data point represents means + S.E. of three to eight determina- 
tions from three separate liver BLMV preparations. 
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Fig. 2. Effect of incubation medium osmolarity on RF uptake by liver 
BLMV. Vesicles were preloaded with a buffer of 280 mM mannitol and 
20 mM Hepes/Tris, pH 7.4. Incubation was performed for 30 rain at 
37°C in a buffer of 140 mM NaC1, 20 mM Hepes/Tris pH 7.4, and 
different amounts of mannitol. [3H]RF (0.11 /xM) was added to the 
incubation medium at the onset of incubation. Each data point represents 
means+S.E, of three to six determinations from two separate liver 
BLMV preparations. 
=5), 1.03_0.10 (n=6) ,  1.12_+0.07 (n=6) ,  1.00_ 
0.09 (n = 6) and 1.17 _+ 0.09 (n = 6) pmol/mg protein/5 
s at pH 5, 5.5, 6, 6.5, 7, 7.5, and 8, respectively). 
Fig. 2 shows the uptake of RF (0.11 /xM) by BLMV at 
equilibrium (30 min) as a function of changing the incuba- 
tion medium osmolarity. An inverse and linear (r  = 0.987) 
relationship was found between RF uptake and incubation 
medium osmolarity. Extrapolating the uptake line to infi- 
nite osmolarity intersected the y-axis at approx. 0.127. 
From this finding we calculated that the degree of binding 
of RF to BLM at equilibrium and under isoosmotic ondi- 
tions to be 33.5% while the remaining 66.5% is due to 
transport into an osmotically active intravesicular space. 
The metabolic form of the radioactivity taken up by 
liver BLMV following 30 min incubation with 0.33 /~M 
[3H]RF was also examined, using the TLC system de- 
scribed in Materials and methods. The result showed that 
the majority of the radioactivity (92.4%) taken up by the 
vesicles to be in the form of intact RF. 
3.2. Involvement of a membrane-associated carrier system 
in RF uptake 
To test for the involvement of a membrane-associated 
carrier system in the uptake of RF by liver BLMV, we 
examined the substrate uptake as a function of increasing 
the concentration in the incubation medium (0.11-10/xM). 
Uptake of RF by diffusion and non-specific uptake was 
determined, as described in Materials and methods, and 
was subtracted from total uptake at each RF concentration. 
Saturation was observed in RF uptake as a function of 
concentration (Fig. 3) suggesting the involvement of a 
specialized membrane associated system. The apparent K m 
and Vma x of the saturable uptake process were 3.55 + 0.70 
/zM and 39.89 + 3.24 pmol/mg protein/5 s, respectively. 
To further examine the involvement of a membrane-as- 
sociated carrier system for RF uptake by liver BLMV, we 
examined the effect of cis-addition of 50 /xM unlabeled 
RF and the structural analogs lumiflavin and lumichrome 
on the uptake of 0.11 /xM [3H]RF. The results howed that 
all the three compounds caused significant (P< 0.01) 
inhibition in [3H]RF uptake. The inhibition caused by 
unlabeled RF and lumiflavin (up to 82%) was higher than 
that caused by lumichrome (17%) (uptake of 1.62 ___ 0.13 
(n = 5), 0.32 + 0.08 (n = 5), 0.30 + 0.04 (n = 6) and 1.34 
+ 0.08 (n = 5) pmol/mg protein/5 s for control and in 
the presence of unlabeled RF, lumiflavin, and lumichrome, 
respectively). 
In another study, we tested for possible stimulation of 
[3H]RF efflux from pre-loaded BLMV by trans-addition 
of unlabeled RF as described in Materials and methods. 
The results showed significantly (P  < 0.01) lower [3H]RF 
content in BLMV incubated in the presence of unlabeled 
RF in the incubation medium compared to those incubated 
in its absence (vesicles content of [3H]RF of 6.8 + 1.35 
(n = 5) and 19.16 + 2.1 (n = 6) pmol/mg protein after 30 
s incubation, respectively). 
3.3. Effect of membrane transport inhibitors and trans- 
membrane lectrical potential 
The effect of the membrane transport inhibitors, 
probenecid, DIDS and SITS (all at 1 raM), on the uptake 
of 0.11 /xM RF by liver BLMV was examined. None of 
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Fig. 3. Uptake of RF by liver BLMV as a function of concentration. 
BLMV were preloaded with a buffer of 280 mM mannitol and 20 mM 
Hepes/Tris, pH 7.4. Incubation was performed in a buffer of 140 mM 
NaCI and 20 mM Hepes/Tris, pH 7.4. Different concentrations of RF 
were added to the incubation medium at the onset of incubation. Each 
data point represents means + S.E. of four to seven determinations from 
three separate liver preparations. 
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the inhibitors tested was found to affect RF uptake (uptake 
of 1.14_+0.04 (n=5)  1.10_+0.04 (n=5) ,  1.37±0.12 
(n = 5) and 1.07 _+ 0.11 (n = 5) pmol /mg protein/5 s for 
control and in the presence of probenecid, DIDS and SITS, 
respectively). 
In other studies, we examined the effect of altering 
transmembrane electrical potential on the uptake process 
of RF by liver BLMV. Two well established methods were 
used: an anion substitution method and a valinomycin-in- 
duced K+-diffusion potential [9,17,18]. In the first method, 
uptake of 0.11 ~M RF was examined in the presence of 
anions of different lipid (i.e., membrane) permeability 
(SCN-> NO~ > gluconate ). In such a study, incubation 
with a lipid permeant anion would create a relatively larger 
transient negative intravesicular electrical potential than a 
relatively impermeant anion. The results showed a trend of 
an increase in RF uptake with the decrease in anion 
membrane permeability (uptake of 1.69_+0.17 (n =5), 
1.85±0.06 (n=5)  and 2.61 ±0.11 (n=7)  pmol /mg 
protein/5 s for SCN-, NO 3 and gluconate-, respectively). 
This suggests that the RF uptake by liver BLMV is 
sensitive to alteration in transmembrane electrical poten- 
tial. This suggestion was further confirmed by the finding 
that induction of a transient negative intravesicular space, 
with the use of an outwardly directed K + gradient (K + = 50 
raM, K += 0 mM) and valinomycin (10 /_~g/mg protein), 
caused a slight (though not significant) decrease in RF 
uptake compared to control. The 'voltage clamp' condition 
(K + = K~ -- 50 mM plus valinomycin) resulted in a slight 
(though not significant) increase in RF uptake following 
induction of a transient positive intravesicular space with 
the use of an inwardly directed K + gradient (K + = 0 mM, 
K += 50 raM) and valinomycin (uptake of 1.72 _+ 0.38 
(n=5) ,  2.0_+0.25 (n=6)  and 2.26±0.12 (n=5)  
pmol /mg protein/5 s, respectively). 
4. Discussion 
The present study examined RF uptake by rat liver 
BLMV isolated by a well established technique. We used 
this liver preparation i order to eliminate the interference 
of RF metabolism by flavokinase and FAD synthetase (the 
liver contains significant activities of these enzymes [6,7]) 
with the uptake process. Furthermore, with this liver 
preparation the interference of uptake across the canalicu- 
lar membrane domain, a problem associated with the use 
of isolated hepatocytes in suspension, was eliminated. 
Uptake of RF was occurred without metabolic alteration of 
the RF molecule confirming the suitability of this prepara- 
tion. RF uptake by liver BLMV was found to be Na+-inde - 
pendent in nature, as indicated by the similar uptake in 
BLMV incubated in the presence of imposed Na + and a 
K + gradients. This is in agreement with a previous obser- 
vation made in isolated hepatocytes [5], and with recent 
findings for RF transport across plasma membranes of 
other cell types including those of mammalian small intes- 
tine and Xenopus  laevis oocytes [13,16,19-21]. This may 
suggest a universal nature of RF uptake process across 
biological membranes. The uptake of RF was also found to 
be pH-independent as indicated by the lack of an effect of 
incubation buffer pH on the substrate uptake. The study on 
the effect of incubation medium osmolarity on RF uptake 
revealed that the uptake process is a composed of transport 
into an osmotically active intravesicular space (66.5%), 
and binding to membrane surfaces (33.5%). In this study, 
our focus was to characterize the overall uptake process of 
RF by BLMV with a special emphasis on the existence of 
a BLM-associated uptake system. 
The uptake process of RF by liver BLMV involved a 
specialized membrane-associated carrier system. Evidence 
for this includes the saturation in RF uptake as a function 
of increasing the substrate concentration i the incubation 
medium, cis- inhibit ion in [3H]RF uptake by unlabeled RF 
and its structural analogs lumiflavin and lumichrome, and 
trans-st imulat ion of [3H]RF efflux from pre-loaded BLMV 
by unlabeled RF in the incubation medium. The ability of 
unlabeled RF and lumiflavin, when added to the incubation 
medium, to cause up to 82% inhibition in [3H]RF uptake 
indicates that both components of the uptake process, i.e., 
transport into the intravesicular spaces and binding to 
BLM, are affected by such treatments and are specific. 
Previous studies have reported that probenecid may 
interfere with RF transport in the kidney, i.e., RF behaves 
like an anion in its transport characteristic [21]. For this 
reason, we tested the effect of probenecid on the uptake of 
[3H]RF by liver BLMV. No effect, however, was seen, 
suggesting that RF does not utilize a probenecid-sensitive, 
general anion uptake system. This was further supported 
by the findings that the anion transport inhibitors DIDS 
and SITS also had no effect on RF uptake by liver BLMV. 
The role of transmembrane electrical potential in RF 
uptake by liver BLMV was also investigated by two 
independent methods. A trend was found in that induction 
of a transient intravesicular positive intravesicular electri- 
cal potential causes slight stimulation in the uptake of RF 
compared to control values, while induction of a transient 
negative intravesicular electrical potential causes a slight 
inhibition in RF uptake by liver BLMV. Since RF exists in 
the neutral (uncharged) form at physiological pH values 
(pK~ of RF = 10.2; pK b = 1.7) and since the uptake pro- 
cess for RF appears to be Na + and pH-independent, these 
findings suggest that transmembrane electrical potential 
may influence, to a certain degree, the activity of the 
putative RF uptake carrier itself. 
In summary, the findings of the present study describe 
for the first time the mechanism of RF uptake across the 
liver BLM using BLMV and demonstrate he involvement 
of a membrane-associated carrier system. This system 
appears to be Na +- and pH-independent and is influenced, 
to a certain degree, by alterations in transmembrane el c- 
trical potential. 
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